Curriculum Vitae
Israa Alakhras Aljnadi
Identification
Personal identification
- Full name
- Israa Alakhras Aljnadi
- Date of birth
- 1990/01/01
- Gender
- Female
Citation names
- Israa M. Aljnadi
- Aljnadi, I
- Aljnadi, Israa
Author identifiers
- Ciência ID
- C318-7400-8BF1
- ORCID iD
- 0000-0003-1721-0373
Email addresses
- israa.aljnadi@campus.ul.pt (Professional)
- asrdavid.89@hotmail.com (Personal)
Addresses
- Av. Prof. Gama Pinto, Faculty of Pharmacy, Universidade de Lisboa, 1649-003 , Lisboa, Lisboa, Portugal (Professional)
- Av. Eng. Arantes e Oliveira 4, 5th floor, 1900-222, Lisbon, Lisbon, Portugal (Personal)
Websites
- https://sbmm.rd.ciencias.ulisboa.pt/ (Professional)
- https://imed.ulisboa.pt/members/israa-alakhras-aljnadi/ (Professional)
Knowledge fields
- Medical and Health Sciences - Basic Medicine - Pharmacology and pharmacy
- Medical and Health Sciences - Medical Biotechnology - Biomaterials
- Medical and Health Sciences - Basic Medicine - Medicinal Chemistry
- Exact Sciences - Computer and Information Sciences - Bioinformatics
- Medical and Health Sciences - Health Sciences
Languages
| Language | Speaking | Reading | Writing | Listening | Peer-review |
|---|---|---|---|---|---|
| Arab (Mother tongue) | |||||
| English | Advanced (C1) | Advanced (C1) | Advanced (C1) | Advanced (C1) | Upper intermediate (B2) |
| Portuguese | Upper intermediate (B2) | Upper intermediate (B2) | Upper intermediate (B2) | Upper intermediate (B2) |
Education
| Degree | Classification | |
|---|---|---|
|
2021/04/01 - 2025/04/01
Ongoing
|
Ph.D in pharmacy (Pós-Graduação)
Major in Ph.D in pharmaceutical and therapeutic chemistry
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
|
|
2018/09/15 - 2020/12/18
Concluded
|
Master's degree in biopharmaceutical sciences (Mestrado)
Major in Biopharmaceutical sciences
Universidade de Lisboa Faculdade de Farmácia, Portugal
"Bonding Microbial Glycolipids To Medical Grade Silicone Surface For Biofilm Formation Prevention" (THESIS/DISSERTATION)
|
17 |
|
2008/09/01 - 2013/09/13
Concluded
|
Pharmacy (Bachelor)
Major in Pharmaceutical sciences
Syrian Private University, Syria
"Duchenne muscular dystrophy (DMD) - Diagnosis and Treatment " (THESIS/DISSERTATION)
|
82.59 |
Affiliation
Science
| Category Host institution |
Employer | |
|---|---|---|
| 2019/09/01 - Current | Researcher (Research) | Research Institute for Medicines (iMed.ULisboa), Portugal |
| Universidade de Lisboa Faculdade de Farmácia, Portugal |
Other Careers
| Category Host institution |
Employer | |
|---|---|---|
| 2017/11/01 - 2018/05/01 | Assessor (Farmacêutica) | Masters Pharma, Syria |
| 2011/06/01 - 2018/05/01 | Assistente (Farmacêutica) | Private Pharmacy, Syria |
| Private organization, Syria |
Projects
Grant
| Designation | Funders | |
|---|---|---|
| 2023 - Current | Inquiring the druggability of DNAG4-helicase interactions with small molecules
2022.06099.PTDC
PhD Student Fellow
|
Fundação para a Ciência e a Tecnologia
Ongoing
|
| 2018/09/01 - 2020/12/18 | Prevention of biofilm formation using glycolipids bonded onto medical devices surface
xvxv
Master Student Fellow
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
Associação para a Inovação e Desenvolvimento da FCT
Concluded
|
Outputs
Publications
| Conference abstract |
|
| Conference poster |
|
| Journal article |
|
Activities
Oral presentation
| Presentation title | Event name Host (Event location) |
|
|---|---|---|
| 2023/09/13 | Development of G4-helicase interaction inhibitors for cancer therapy | Bio3Pharm, French - Portuguese Symposium
IECB ,European Institute of Chemistry and Biology, Pessac, Université de Bordeaux (Bordeaux, France)
|
| 2023/06/26 | Inhibitors of Helicase-Mediated c-MYC G-quadruplex Unfolding for Cancer Therapy | iMed.Ulisboa 14th Meeting 2023(ipSC)
Faculdade de Farmacia (lisbon, Portugal)
|
| 2023/01/23 | Inhibition of G4-Helicase Interactions: A Promising Approach for Cancer Targeting Therapy | The 15th National Organic Chemistry Meeting (15ENQO), and the 8th National Medicinal Chemistry Meeting (8ENQT)
at University of Algarve, Gambelas campus,Faro, Portugal. (Faro, Portugal)
|
| 2022/12/21 | In Silico Studies and Chemical Synthesis of Ligands Targeting Parallel G-Quadruplexes | 3D-BIOINFO-PT- Annual Meeting
The Portuguese Community of Structural Bioinformatics Researchers, ITQB NOVA (lisbon, Portugal)
|
| 2021/06/25 | In Silico studies for developing new cancer therapeutics targeting DNA G-quadruplexes | The Computationally Driven Drug Discovery Meeting, CDDD 7th Virtual Meeting,
Divisione di Chimica Farmaceutica, Società Chimica Italiana (Division of Medicinal Chemistry, Italian Chemical SocietyI) (milano, Italy)
|
Association member
| Society Organization name | Role | |
|---|---|---|
| 2017/11/01 - 2018/05/01 | As a manager of the development office in Maters Pharma company, I was responsible to manage the communications with the companies of final oncological products around the world. I was in charge of developing and expanding the work of the company by contacting new suppliers and companies in Europe. | manager of the development office in Maters Pharma company |
Consulting
| Activity description | Institution / Organization | |
|---|---|---|
| 2011/06/01 - 2018/05/01 | As a community pharmacist, I was responsible for medication dispensing, prescription, and preparation. In addition to the patient consultations for OTC. Moreover, I was in charge of pharmacy management as a financial project. |
Distinctions
Other distinction
| 2023 | FCT Grant
Fundação para a Ciência e a Tecnologia, Portugal
|
| 2018 | Grant of Global Platform for Syrian Students |
| 2008 | Grant from Syrian Ministry of High Education for degree in pharmacy |